Noah Friedman is leading corporate strategy projects with a focus on an approach to business in China that accounts for complex market and geopolitical dynamics. In addition, he is the head of the sales & marketing training function and co-sponsors the regional Market Development & Innovation Council. He is a trusted advisor to global ExCom and the Board regarding Medtronic’s approach in China’s dynamic market.

Noah joined Medtronic in 2006 in Minneapolis and held marketing roles in Neuromodulation and Diabetes OUs in the USA. He moved to Shanghai in 2010 as China business leader for peripheral vascular therapies and, since 2012 has led the regional strategy team. Over the years, he has played a founding role to establish Medtronic’s approach to China’s broad market and private hospital segments, guide a series of investments in Chengdu for innovation and physician training, and helped establish and advise Medtronic’s venture investment fund for China.

Noah is passionate about bridging China and the world. Noah hails from New York where he started studying Chinese at a young age, and he has lived in Shanghai, Beijing, and Nanjing for a total of sixteen years. He holds an MBA from the Harvard Business School and a bachelor’s degree in economics and East Asian Studies from Yale University.